Continuation of Voluntary Suspension
Filed with ASX · · 1 page · English
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Agreement to Return US$2M to Obsidian
- Phase 3 Interim Result Below Continuation Threshold
- Suspension from Quotation
- Appendix 4E and 2026 Annual Report
- June 2026 Quarterly Activities Report & Appendix 4C
Later from Paradigm Biopharmaceuticals
- Board Initiates Voluntary Administration
- Appointment of Voluntary Administrators
- Continuation of Suspension from Quotation
- PPS Shows Significant Pain Benefit in Rest of World Analysis
- Extension of Convening Period
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals